{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:27:56Z","timestamp":1790274476569,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vaccine.2024.02.011","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T22:14:27Z","timestamp":1708380867000},"page":"1953-1965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Liposomal co-encapsulation of a novel gemini lipopeptide and a CpG-ODN induces a strong Th1 response with the co-activation of a Th2\/Th17 profile and high antibody levels"],"prefix":"10.1016","volume":"42","author":[{"given":"Ivana Gabriela","family":"Reidel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia Carol","family":"Curti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9556-1822","authenticated-orcid":false,"given":"L\u00e9a","family":"Dor\u00e9mus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7522-2762","authenticated-orcid":false,"given":"Emile","family":"B\u00e9r\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Delwail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina Cecilia","family":"Russi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Lecron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3812-9304","authenticated-orcid":false,"given":"Franck","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda In\u00e9s","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Mar\u00eda","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9703-5976","authenticated-orcid":false,"given":"Jean-Fran\u00e7ois","family":"J\u00e9gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Melania","family":"Veaute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.02.011_b0005","first-page":"S2","article-title":"Evolution, benefits, and shortcomings of vaccine management","volume":"13","author":"McCullers","year":"2007","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.vaccine.2024.02.011_b0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41577-020-00479-7","article-title":"A guide to vaccinology: from basic principles to new developments","volume":"21","author":"Pollard","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.02.011_b0015","first-page":"1","article-title":"Successful vaccines","volume":"428","author":"Amanna","year":"2020","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2024.02.011_b0020","article-title":"An overview of vaccine adjuvants: current evidence and future perspectives","volume":"10","author":"Facciol\u00e0","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.02.011_b0025","doi-asserted-by":"crossref","first-page":"12294","DOI":"10.1073\/pnas.1400478111","article-title":"Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants","volume":"111","author":"Maisonneuve","year":"2014","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2024.02.011_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.880474","article-title":"Monocytes elicit a neutrophil-independent Th1\/Th17 response upon immunization with a mincle-dependent glycolipid adjuvant","volume":"13","author":"Desel","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.02.011_b0035","doi-asserted-by":"crossref","unstructured":"Zhang F, Ledue O, Jun M, Goulart C, Malley R, Lu YJ. Protection against staphylococcus aureus colonization and infection by B- and T-cell-mediated mechanisms. mBio. 2018;9.","DOI":"10.1128\/mBio.01949-18"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2024.02.011_b0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/1469-0691.12570","article-title":"Where does a Staphylococcus aureus vaccine stand?","volume":"20","author":"Fowler","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2024.02.011_b0045","first-page":"01","article-title":"Effects of the liposomal co-encapsulation of antigen and PO-CpG oligonucleotide on immune response in mice","volume":"3","author":"Reidel","year":"2017","journal-title":"Int J For Res In Appl Natural Sci"},{"key":"10.1016\/j.vaccine.2024.02.011_b0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4236\/aces.2017.72014","article-title":"New amphiphilic amino acid derivatives for efficient DNA transfection in vitro","volume":"7","author":"Pe\u00f1a","year":"2017","journal-title":"Adv Chem Eng Sci"},{"key":"10.1016\/j.vaccine.2024.02.011_b0055","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s12010-019-02999-y","article-title":"Activity-structure study on the peptide fraction of AG2: a potent in vitro transfection agent","volume":"189","author":"Grippo","year":"2019","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.vaccine.2024.02.011_b0060","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1111\/febs.12041","article-title":"Lipoproteins in bacteria: structures and biosynthetic pathways","volume":"279","author":"Nakayama","year":"2012","journal-title":"FEBS J"},{"key":"10.1016\/j.vaccine.2024.02.011_b0065","doi-asserted-by":"crossref","first-page":"22955","DOI":"10.1021\/acsomega.1c03620","article-title":"Gemini lipopeptide bearing an ultrashort peptide for enhanced transfection efficiency and cancer-cell-specific cytotoxicity","volume":"6","author":"Ravula","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.vaccine.2024.02.011_b0070","doi-asserted-by":"crossref","first-page":"159","DOI":"10.7774\/cevr.2020.9.2.159","article-title":"Gemini lipopeptides as vaccine adjuvants: a new role for these versatile carriers","volume":"9","author":"Grippo","year":"2020","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2024.02.011_b0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.rvsc.2022.02.014","article-title":"Efficacy of immunization with a recombinant S. aureus vaccine formulated with liposomes and ODN-CpG against natural S. aureus intramammary infections in heifers and cows","volume":"145","author":"Camussone","year":"2022","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2024.02.011_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2019.04.011","article-title":"Liposomal and CpG-ODN formulation elicits strong humoral immune responses to recombinant Staphylococcus aureus antigens in heifer calves","volume":"212","author":"Reidel","year":"2019","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2024.02.011_b0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/jid.2014.289","article-title":"The skin immune atlas: three-dimensional analysis of cutaneous leukocyte subsets by multiphoton microscopy","volume":"135","author":"Tong","year":"2015","journal-title":"J, Invest Dermatol"},{"key":"10.1016\/j.vaccine.2024.02.011_b0090","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1016\/j.vaccine.2012.03.040","article-title":"Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis","volume":"30","author":"Shargh","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.02.011_b0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/08982104.2011.584319","article-title":"Fast high-throughput screening of temoporfin-loaded liposomal formulations prepared by ethanol injection method","volume":"22","author":"Yang","year":"2012","journal-title":"J Liposome Res"},{"key":"10.1016\/j.vaccine.2024.02.011_b0100","series-title":"Fmoc solid phase peptide synthesis: a practical approach","author":"Chan","year":"1999"},{"key":"10.1016\/j.vaccine.2024.02.011_b0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tvjl.2018.03.005","article-title":"Evaluation of the humoral immune response to a multicomponent recombinant vaccine against S. aureus in healthy pregnant heifers","volume":"235","author":"Pujato","year":"2018","journal-title":"Vet J"},{"key":"10.1016\/j.vaccine.2024.02.011_b0110","series-title":"Statistical methods","author":"Snedecor","year":"1989"},{"key":"10.1016\/j.vaccine.2024.02.011_b0115","unstructured":"National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. 2011."},{"key":"10.1016\/j.vaccine.2024.02.011_b0120","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2024.02.011_b0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/cei.12841","article-title":"The genetic background influences the cellular and humoral immune responses to vaccines","volume":"186","author":"Zeng","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2024.02.011_b0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tube.2014.10.012","article-title":"BALB\/c mice display more enhanced BCG vaccine induced Th1 and Th17 response than C57BL\/6 mice but have equivalent protection","volume":"95","author":"Garcia-Pelayo","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2024.02.011_b0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1166\/jcsb.2012.1020","article-title":"Preparation, characterization and applications of liposomes: state of the art","volume":"1","author":"Laouini","year":"2012","journal-title":"J Colloid Sci Biotechnol"},{"key":"10.1016\/j.vaccine.2024.02.011_b0140","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1529\/biophysj.103.033480","article-title":"Nanostructure of cationic lipid-oligonucleotide complexes","volume":"87","author":"Weisman","year":"2004","journal-title":"Biophys J"},{"key":"10.1016\/j.vaccine.2024.02.011_b0145","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1007\/s00216-017-0527-z","article-title":"Zeta potential: a case study of cationic, anionic, and neutral liposomes","volume":"409","author":"Smith","year":"2017","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.vaccine.2024.02.011_b0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/2051013614541440","article-title":"Liposomes as vaccine delivery systems: a review of the recent advances","volume":"2","author":"Schwendener","year":"2014","journal-title":"Ther Adv Vaccines"},{"key":"10.1016\/j.vaccine.2024.02.011_b0155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/ilar.46.3.241","article-title":"Applications and optimization of immunization procedures","volume":"46","author":"Schunk","year":"2005","journal-title":"ILAR J"},{"key":"10.1016\/j.vaccine.2024.02.011_b0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.addr.2008.12.013","article-title":"Innovative strategies for co-delivering antigens and CpG oligonucleotides","volume":"61","author":"Krishnamachari","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2024.02.011_b0165","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2147\/IJN.S30197","article-title":"Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system","volume":"7","author":"Hanagata","year":"2012","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.vaccine.2024.02.011_b0170","doi-asserted-by":"crossref","first-page":"758","DOI":"10.5483\/BMBRep.2011.44.11.758","article-title":"Adjuvant effect of liposome-encapsulated natural phosphodiester CpG-DNA","volume":"44","author":"Kim","year":"2011","journal-title":"BMB Rep"},{"key":"10.1016\/j.vaccine.2024.02.011_b0175","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1128\/jvi.71.11.8109-8115.1997","article-title":"Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2","volume":"71","author":"Parr","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.02.011_b0180","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1073\/pnas.1012861108","article-title":"Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection","volume":"108","author":"Li","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2024.02.011_b0185","doi-asserted-by":"crossref","first-page":"16010","DOI":"10.1038\/npjvaccines.2016.10","article-title":"Intradermal immunisation using the TLR3-ligand Poly (I:C) as adjuvant induces mucosal antibody responses and protects against genital HSV-2 infection","volume":"1","author":"Bardel","year":"2016","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2024.02.011_b0190","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/cmi.2014.41","article-title":"Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection","volume":"11","author":"Nguyen","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2024.02.011_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21645515.2017.1281488","article-title":"A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infection","volume":"13","author":"Yang","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2024.02.011_b0200","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s10529-010-0283-z","article-title":"Antigenic features of protein carriers commonly used in immunisation trials","volume":"32","author":"Chiarella","year":"2010","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.vaccine.2024.02.011_b0205","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1504\/IJBNN.2010.034656","article-title":"Gemini nanoparticles as a co-delivery system for antigen-CpG oligodeoxynucleotide adjuvant combination","volume":"1","author":"Badea","year":"2010","journal-title":"IJBNN"},{"key":"10.1016\/j.vaccine.2024.02.011_b0210","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.0802830","article-title":"CD8 T cells producing IL-17 and IFN-gamma initiate the innate immune response required for responses to antigen skin challenge","volume":"182","author":"Kish","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.02.011_b0215","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000487756","article-title":"Neutrophils and bacterial immune evasion","volume":"10","author":"Kobayashi","year":"2018","journal-title":"J Innate Immun"},{"key":"10.1016\/j.vaccine.2024.02.011_b0220","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10517-011-1268-1","article-title":"Morphofunctional characteristic of the immune system in BALB\/c and C57BL\/6 mice","volume":"151","author":"Trunova","year":"2011","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.vaccine.2024.02.011_b0225","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/ncomms2874","article-title":"High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway","volume":"4","author":"Volpi","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2024.02.011_b0230","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.4049\/jimmunol.1103668","article-title":"Engineering DNA nanoparticles as immunomodulatory reagents that activate regulatory T cells","volume":"188","author":"Huang","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.02.011_b0235","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2147\/IJN.S68861","article-title":"Liposomes as nanomedical devices","volume":"10","author":"Bozzuto","year":"2015","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.vaccine.2024.02.011_b0240","doi-asserted-by":"crossref","unstructured":"Tandrup Schmidt S, Foged C, Korsholm KS, Rades T, Christensen D. Liposome-based adjuvants for subunit vaccines: formulation strategies for subunit antigens and immunostimulators. Pharmaceutics. 2016;8.","DOI":"10.3390\/pharmaceutics8010007"},{"key":"10.1016\/j.vaccine.2024.02.011_b0245","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.molimm.2017.07.013","article-title":"Investigations on the molecular mode of action of the novel immunostimulator ZelNate: Activation of the cGAS-STING pathway in mammalian cells","volume":"90","author":"Ilg","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2024.02.011_b0250","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2471\/BLT.10.079426","article-title":"Intradermal delivery of vaccines: potential benefits and current challenges","volume":"89","author":"Hickling","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2024.02.011_b0255","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jconrel.2016.04.030","article-title":"Chemical penetration enhancers in stratum corneum - Relation between molecular effects and barrier function","volume":"232","author":"Pham","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2024.02.011_b0260","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejpb.2015.02.024","article-title":"Novel serine-based gemini surfactants as chemical permeation enhancers of local anesthetics: A comprehensive study on structure-activity relationships, molecular dynamics and dermal delivery","volume":"93","author":"Teixeira","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.vaccine.2024.02.011_b0265","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijpharm.2017.06.083","article-title":"Pharmaceutical versatility of cationic niosomes derived from amino acid-based surfactants: Skin penetration behavior and controlled drug release","volume":"529","author":"Muzzalupo","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2024.02.011_b0270","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1189\/jlb.1003524","article-title":"Synergistic induction of CXCL9 and CXCL11 by Toll-like receptor ligands and interferon-gamma in fibroblasts correlates with elevated levels of CXCR3 ligands in septic arthritis synovial fluids","volume":"75","author":"Proost","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2024.02.011_b0275","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fmed.2018.00271","article-title":"The role of CXCR3 and its chemokine ligands in skin disease and cancer","volume":"5","author":"Kuo","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.vaccine.2024.02.011_b0280","series-title":"Encyclopedia of respiratory medicine","first-page":"357","article-title":"CXC chemokine family","author":"Williams","year":"2022"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T10:40:56Z","timestamp":1714992056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24001579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0264410X24001579"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liposomal co-encapsulation of a novel gemini lipopeptide and a CpG-ODN induces a strong Th1 response with the co-activation of a Th2\/Th17 profile and high antibody levels","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}